Literature DB >> 9164065

Fixed drug eruption caused by iopamidol, a contrast medium.

R Yamauchi1, A Morita, T Tsuji.   

Abstract

We report a patient who developed a fixed drug eruption caused by the contrast medium, Iopamidol. We diagnosed it by her episode pattern and the results of patch tests. This substance has not been previously implicated as a cause of fixed drug eruption. Immunohistochemical studies showed Fas expression in keratinocytes of the lesion, but not in the uninvolved skin. This finding may explain the preferential localization of fixed drug eruption.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9164065     DOI: 10.1111/j.1346-8138.1997.tb02781.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  5 in total

Review 1.  A practical guide to diagnose lesser-known immediate and delayed contrast media-induced adverse cutaneous reactions.

Authors:  Ingrid Böhm; Hans H Schild
Journal:  Eur Radiol       Date:  2006-04-20       Impact factor: 5.315

2.  Fixed drug eruption induced by an iodinated non-ionic X-ray contrast medium: a practical approach to identify the causative agent and to prevent its recurrence.

Authors:  Ingrid Böhm; Jesus Medina; Pilar Prieto; Wolfgang Block; Hans H Schild
Journal:  Eur Radiol       Date:  2006-08-26       Impact factor: 5.315

3.  Monitoring non-immediate allergic reactions to iodine contrast media.

Authors:  M J Torres; C Mayorga; J A Cornejo-Garcia; S Lopez; P Chaves; C Rondon; T Fernandez; M Blanca
Journal:  Clin Exp Immunol       Date:  2008-03-12       Impact factor: 4.330

4.  Fixed Drug Eruption due to Iopromide (Ultravist®).

Authors:  Sang Hee Cha; Hei Sung Kim; Jun Young Lee; Hyung Ok Kim; Young Min Park
Journal:  Ann Dermatol       Date:  2011-09-30       Impact factor: 1.444

Review 5.  The Role of Patch Testing in Evaluating Delayed Hypersensitivity Reactions to Medications.

Authors:  Carina M Woodruff; Nina Botto
Journal:  Clin Rev Allergy Immunol       Date:  2022-02-03       Impact factor: 10.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.